IMRX$3.70+6.02%
Immuneering Corp
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$239.62M
Float & O/S:
Inst Own:
DilutionScan read 31 of Immuneering Corp's SEC filings and found 2 warrant series, 2 ATM programs, 3 shelf registrations and 2 completed offerings on file for IMRX. The latest dilution event on file is ATM sales on Sep 30, 2026. Analysis updated Oct 31, 2026.